BioMed and BioSci Advances is a cutting-edge, peer-reviewed journal dedicated to advancing the frontiers of biomedical and biological sciences. Our mission is to provide a global platform for researchers, clinicians, and innovators to publish high-impact discoveries that drive progress in human health, disease mechanisms, and biotechnology. By fostering interdisciplinary collaboration, we bridge the gap between fundamental research and clinical applications, accelerating the translation of scientific breakthroughs into real-world solutions. The journal publishes original research articles, authoritative reviews/perspectives, and concise communications spanning a broad spectrum of topics, including Molecular and Cellular Biology, Genetics and Genomics, Immunology and Infectious Diseases, Neuroscience and Neurodegeneration, Cancer Biology and Precision Oncology, Regenerative Medicine and Stem Cell Therapy, Pharmacology and Drug Development, Biomedical Engineering and Nanomedicine, Systems Biology and Bioinformatics, Public Health and Epidemiology, Structural Biology and Proteomics, and Translational Medicine. With a commitment to open science and innovation, BioMed and BioSci Advances highlights emerging technologies such as CRISPR and gene editing, AI-driven diagnostics, wearable biosensors, organ-on-a-chip systems, and next-generation therapeutics. We also emphasize One Health approaches, linking human, animal, and environmental health to address global challenges like antimicrobial resistance and pandemic preparedness. By uniting diverse perspectives—from bench scientists to clinical practitioners—we aim to catalyze breakthroughs that redefine medicine and improve lives. BioMed and BioSci Advances serves as a vital resource for the scientific community, policymakers, and industry leaders, empowering them with knowledge to shape a healthier, more sustainable future.
Pravin S. Bhale, Nikita N. Mali, Sadanand N. Shringare, Tukaram D. Jadhav, Dipak S. Bhandigare, Dnyaneshwar M. Sirsat
Summary: This review explores the design, synthesis, and therapeutic applications of carbohydrate-isoxazole hybrids in drug discovery. Focusing on their biological activities, structure-activity relationships, and mechanisms of action, it discusses their potential in treating diverse conditions such as cancer, inflammation, and infections. The study emphasizes the importance of rational design in optimizing these hybrids, while addressing challenges like metabolic stability and selective targeting, offering insights for future drug development strategies.
BioMed and BioSci Advances 2(2), 63-73 (2025)
https://doi.org/10.69626/bba.2025.0063Muzamil Liakat Mir, Nuzhat Parveen, Shahid Bin Zeya, Ramsha Ashraf, Amreen Fatima, Suhaima Safdar, Sana Jameel, Faiqua Haque, G.G.H.A. Shadab
Summary: This review explores the application of DNA barcoding in insect taxonomy, focusing on its role in species identification, biodiversity assessment, and ecological research. It examines advancements in non-destructive DNA extraction methods and the integration of next-generation sequencing, portable technologies, and AI. The study also addresses challenges such as database limitations and numts, offering insights into how these issues can be overcome to improve the reliability and effectiveness of DNA barcoding in entomology and conservation.
BioMed and BioSci Advances 2(2), 74-95 (2025)
https://doi.org/10.69626/bba.2025.0074Roshana K. Hushare, R. B. Gade, M. T. Nikam
Summary: The study investigated the diversity and seasonal abundance of butterflies in Chikhli, Buldhana District, from June to September 2022. Seventeen species across five families were recorded, with the Nymphalidae family dominating. Highest diversity was found in grasslands, scrub jungles, and agricultural peripheries, peaking during the monsoon. Seasonal variations in butterfly populations were linked to host plant availability and climatic conditions. The study emphasizes the need for habitat conservation to protect butterfly populations and floral diversity.
BioMed and BioSci Advances 2(2), 96-104 (2025)
https://doi.org/10.69626/bba.2025.0096Mat Both Dol, Delelegn Woyessa, Shiferaw Demissie, M. Sadre Alam Fakhri
Summary: This research isolated and characterized native Trichoderma strains from tomato rhizospheres in Ethiopia to evaluate their antagonistic effects against P. infestans. Ten isolates were obtained, and four strains exhibited substantial growth inhibition of the pathogen, with Ju-TGDb-2 showing the highest efficacy (61.4%). These findings suggest that native Trichoderma isolates can be used as effective biocontrol agents, offering a promising solution for managing late blight in tomatoes.
BioMed and BioSci Advances 2(2), 105-113 (2025)
https://doi.org/10.69626/bba.2025.0105.Muzamil Liakat Mir, Nuzhat Parveen, Amreen Fatima, Suhaima Safdar, Faiqua Haque, G.G.H.A. Shadab
Summary: This review consolidates research on AgNP-induced genotoxicity, emphasizing DNA damage, chromosomal aberrations, and epigenetic modifications. It explores synthesis methods, characterization techniques, and toxicity mechanisms, including ROS generation and mitochondrial dysfunction. Comparative analysis of in vitro and in vivo studies reveals dose- and size-dependent effects, urging standardized testing protocols. The study advocates for balanced risk-benefit assessments, proposing safer AgNP alternatives and regulatory measures to mitigate risks while harnessing their antimicrobial and industrial potential for sustainable advancements.
BioMed and BioSci Advances 2(1), 01-22 (2025)
https://doi.org/10.69626/bba.2025.0001Mohd Zaid Khan, Faiqua Haque
Summary: Histopathological analysis revealed that pyrethroid exposure induces significant liver necrosis, cardiac atrophy, and renal tubular damage in animal models. Mosquito coil smoke caused the most severe toxicity, while antioxidant treatments showed partial protection. The study confirms pyrethroids’ multi-organ toxicity through oxidative stress and metabolic dysfunction, emphasizing the need for stricter exposure guidelines and alternative pest control strategies to mitigate long-term health risks in humans and wildlife.
BioMed and BioSci Advances 2(1), 23-38 (2025)
https://doi.org/10.69626/bba.2025.0023Darshan Hosmath, Jaysing Patil
Summary: The study isolated and characterized glucoamylase-producing bacteria from fruit waste soil in Tasawade MIDC, Karad. Among four isolates, T5 showed the highest activity (176.45 U/ml/min) and specific activity (309.56 U/mg). Optimal conditions were pH 6, 25°C, 0.2 mg/ml salt, and 2.5 mg/ml substrate, with MgCl₂ enhancing activity. T5, a Gram-positive coccus, demonstrated robust enzyme stability. The findings suggest its industrial potential in starch processing and biofuels, emphasizing sustainable microbial enzyme production from organic waste for eco-friendly biotechnological applications.
BioMed and BioSci Advances 2(1), 39-45 (2025)
https://doi.org/10.69626/bba.2025.0039Alvia Farheen , Mukhtar Ahmad Khan, Noorin Zafar
Summary: The study evaluated black pepper’s effects on Channa punctatus fingerlings, finding that 0.4% dietary inclusion significantly improved weight gain, growth rate, protein retention, and feed efficiency while reducing FCR. Higher doses reduced palatability and growth. Hematological parameters (hemoglobin, RBC, hematocrit) peaked at 0.4%, indicating better oxygen transport and metabolism. Black pepper enhanced protein deposition without altering fat or ash content. The results suggest its viability as a natural growth enhancer in sustainable aquaculture.
BioMed and BioSci Advances 2(1), 46-54 (2025)
https://doi.org/10.69626/bba.2025.0046Gatluak Goanar, Geremew Tafesse, Workineh Mengesha, M. Sadre Alam Fakhri
Summary: The study evaluated the antibacterial efficacy of acetone and ethanol extracts from Tamarindus indica leaves against S. aureus and K. pneumoniae using disk diffusion and MIC assays. Both extracts showed significant antibacterial activity, with K. pneumoniae being more sensitive. The acetone extract exhibited lower MIC values (9.375 mg/mL) than ethanol (18.75 mg/mL). Results suggest that tamarind leaves contain bioactive compounds with therapeutic potential, supporting their traditional use. Further research is needed to isolate active constituents and assess mechanisms of action.
BioMed and BioSci Advances 2(1), 55-62 (2025)
https://doi.org/10.69626/bba.2025.0055Sadik Tyagi, Mohd Aarim, Salman Khan, Bushra Ahmad, Muzammil Liyakat Mir, Faiqua Haque, Suhaima Safdar, Amreen Fatima, Nuzhat Parveen, G.G.H.A. Shadab
Summary: Nanoparticles (NPs) enable breakthroughs in drug delivery through targeted, stimuli-responsive systems like liposomes and dendrimers, improving therapeutic outcomes in oncology and neurology. Innovations in green synthesis and DNA nanotechnology enhance sustainability and precision. Challenges include regulatory standardization, toxicity assessment, and scalable production. Future prospects involve AI-optimized designs, gene-editing carriers, and personalized nanomedicine. Interdisciplinary collaboration and ethical frameworks are vital for translating lab advancements into clinical practice, ensuring NPs redefine 21st-century medicine safely and equitably.
BioMed and BioSci Advances 1(1), 03-25 (2024)
https://doi.org/10.69626/bba.2024.0003Sabahat Ariba, Monisha Banerjee
Summary: This comprehensive review analyzes BPA’s carcinogenic mechanisms in breast cancer, including receptor-mediated signaling, stromal reprogramming, and subtype-specific effects. It demonstrates how dietary components can exacerbate or counteract BPA’s toxicity through metabolic interactions. The study integrates molecular, epidemiological and clinical evidence to propose a multidisciplinary approach combining regulatory measures, public awareness and nutritional strategies to address BPA-associated breast cancer risks, emphasizing prevention through environmental and lifestyle modifications.
BioMed and BioSci Advances 1(1), 26-39 (2024)
https://doi.org/10.69626/bba.2024.0026Bushra Ahmad, Sadik Tyagi, Mohd. Aarim, Mohd. Sajid Khan, Ahamad Faiz Khan
Summary: The study systematically examines three key enzymes (MCT, CMK, MDS) in the DXP pathway, detailing their roles in converting metabolic intermediates to terpenoid precursors. Through structural and kinetic analyses, it highlights their plastid localization, catalytic mechanisms, and regulatory features. The research bridges gaps in plant isoprenoid biosynthesis, offering insights for biotechnological manipulation of terpenoid production. These discoveries pave the way for sustainable applications in agriculture, medicine, and industry by optimizing natural product synthesis.
BioMed and BioSci Advances 1(1), 40-63 (2024)
https://doi.org/10.69626/bba.2024.0040Gatluak Goanar, Geremew Tafesse, M. Sadre Alam Fakhri
Summary: This study evaluated Tamarindus indica seed extracts (acetone/ethanol, 100-300 mg/mL) against S. aureus and K. pneumoniae using disk diffusion. No inhibition was observed, with no significant difference from the negative control (P = 1.00). Results suggest tamarind seeds lack antibacterial activity under tested conditions but warrant further study with varied methods, solvents, or synergistic combinations to confirm their potential as antimicrobial agents.
BioMed and BioSci Advances 1(1), 64-70 (2024)
https://doi.org/10.69626/bba.2024.0064Anjali Ranjan, Shruti Verma, Gajendra Kumar Azad, Shahla Yasmin
Summary: Arsenic trioxide (0.5–0.75 mM) caused dose-dependent lethality, oxidative stress, and motor deficits in Drosophila. Curcumin (1 mM) co-administration improved survival, reduced lipid peroxidation, and restored catalase activity and climbing ability. Bioinformatics revealed curcumin’s interactions with detoxification proteins like cytochrome P450 and glutathione S-transferases. Results suggest curcumin mitigates arsenic toxicity via antioxidant pathways, advocating its use as a neuroprotective supplement. Further studies in mammalian models are warranted.
BioMed and BioSci Advances 1(1), 71-81 (2024)
https://doi.org/10.69626/bba.2024.0071Dianbao Zhang
BioMed and BioSci Advances 1(1), 01-02 (2024)
https://doi.org/10.69626/bba.2024.0001Welcome to BioMed and BioSci Advances, a cutting-edge, peer-reviewed journal published by Ariston Publications, dedicated to accelerating breakthroughs in biomedical and biological sciences. Our mission is to provide a dynamic platform for researchers, clinicians, and biotechnologists to share pioneering discoveries that advance human health, decode disease mechanisms, and drive innovation in life sciences. By fostering interdisciplinary collaboration, we bridge the gap between fundamental research and clinical translation, ensuring that scientific knowledge translates into real-world impact.
BioMed and BioSci Advances embraces the complexity of modern biomedical research, covering a wide spectrum of disciplines—from molecular biology and genetics to translational medicine and public health. We prioritize cutting-edge studies that push scientific boundaries, whether through novel therapeutics, AI-driven diagnostics, or sustainable biomedical technologies. Our rigorous peer-review process ensures that only high-quality, impactful research is published, while our open-access model promotes global knowledge sharing and inclusivity.
We invite researchers, clinicians, and industry experts worldwide to contribute their groundbreaking work to BioMed and BioSci Advances. Together, we can shape the future of medicine, improve global health outcomes, and foster a deeper understanding of life sciences.
BioMed and BioSci Advances aims to:
BioMed and BioSci Advances covers a broad range of topics in biomedical and biological research, including but not limited to:
BioMed and BioSci Advances provides comprehensive coverage of cutting-edge research across all areas of biomedical and biological sciences, with a strong emphasis on interdisciplinary innovation. We welcome original research, reviews, and clinical studies spanning experimental, theoretical, computational, and translational approaches. Topics include, but are not limited to:
Why Submit to BioMed and BioSci Advances?
Broad Impact: Covering fundamental to applied research with global relevance.
Interdisciplinary Focus: Bridging biology, medicine, engineering, and data science.
Rapid Dissemination: Fast-track review and open-access availability.
We invite researchers to contribute their groundbreaking work to advance the frontiers of biomedicine and bioscience!
BioMed and BioSci Advances engages a global, multidisciplinary audience at the forefront of biomedical and life sciences research. Our readership spans academia, clinical practice, industry, and policy-making, reflecting the journal’s commitment to bridging discovery with real-world impact.
Researchers & Academics
Clinicians & Healthcare Professionals
Industry & Biotechnology Leaders
Policy Makers & Regulatory Experts
Educators & Students
Prof. Dianbao Zhang
Department of Stem Cell and Regenerative Medicine
China Medical University, Shenyang, China
Email: dbzhang@cmu.edu.cn
Prof. Lili Jin
School of Life Sciences
Liaoning University, Shenyang, China
Dr. K. K. Sharma
Professor, Zoology (Retd.) & Former Vice Chancellor
Department of Zoology
Maharshi Dayanand Saraswati University, Ajmer, India
Dr. B. Kumaran
Endocrinology & Toxicology
Indira Gandhi College of Arts and Science
Pondicherry University, Puducherry, India
Prof. Tao Liu
Department of Natural Products Chemistry
China Medical University, Shenyang, China
Prof. Monisha Banerjee
Molecular & Human Genetics Laboratory
Department of Zoology
University of Lucknow, UP, India
Dr. Yiming Yang
College of Basic Medical Sciences
Jilin University, Changchun, China
Dr. Reena Mathur
Professor (Retd.), Department of Zoology
Rajasthan University, Jaipur, Rajasthan, India
Dr. A. Subramanyam
Professor (Retd.), Department of Zoology
Annamalai University, Chennai, Tamilnadu, India
Prof. Huazhe Yang
School of Intelligent Medicine
China Medical University, Shenyang, China
Dr. Syed Musthapa Meeran
Senior Principal Scientist & Professor AcSIR
Department of Biochemistry
CSIR-Central Food Technological Research Institute (CFTRI)
Mysore, Karnataka, India
Prof. Md. Equbal Ahmad
Department of Zoology
M. Bhagalpur University, Bhagalpur, Bihar, India
Dr. Chuyuan Wang
Department of Endocrinology and Metabolism
The First Hospital of China Medical University, Shenyang, China
Dr. Ruchi Jain
Department of Chemistry, SBSS College, Lalit Narayan Mithila University, Darbhanga, Bihar, India
Dr. Sudhir Kumar
Department of Zoology, B. R. D. Post Graduate College,
Deen Dayal Upadhyaya Gorakhpur University
Gorakhpur, Uttar Pradesh, India
Dr. Jiayu Chen
Department of Gastroenterology
Kyoto University, Kyoto, Japan
Dr. Tingting Liu
School of Pharmacy
Liaoning Agricultural Vocational and Technical College, Yingkou, China
Dr. Sam A. Masih
Sam Higginbottom University of Agriculture, Technology and Sciences (SHUATS), Prayagraj, Uttar Pradesh, India
Dr. Yi Xin
School of Management
Tianjin University of Traditional Chinese Medicine, Tianjin, China
Dr. Roli Mathur
Head , ICMR-Bioethics Unit, Bengaluru, India
Prof. Yogesh Rawal
Department of Zoology
Punjab University, Chandigarh, India
Dr. Shahla Yasmeen
Professor & Head, Department of Zoology
Patna University, Patna, Bihar, India
Dr. Ying Li
Medical Research Center
Affiliated Hospital of Jining Medical University, Jining, China
Dr. Boni Amin Laskar
Scientist-E, ZSI-HARC, Solan, Himachal Pradesh, India
Dr. Syed Mohi Alam Rizvi
Department of Zoology
Lalit Narayan Mithila University, Darbhanga, Bihar, India
Dr. Shamsun Nehar
Department of Zoology
Ranchi University, Ranchi, Jharkhand, India
Guide to Reviewers: BioMed and BioSci Advances
Welcome to the Instructions for Reviewers for BioMed and BioSci Advances. As a valued reviewer, your expertise and insights play a crucial role in maintaining the quality and integrity of the journal’s publications. Your thorough evaluation and constructive feedback are instrumental in shaping the direction of scientific discourse in the field of Biomedical, Bioscience, Bioengineering, and Biotechnology. Below are guidelines to assist you in conducting a comprehensive review of manuscripts submitted to BioMed and BioSci Advances.
Guide to Editors: BioMed and BioSci Advances
Welcome to the comprehensive Guide to Editors for BioMed and BioSci Advances. As an editor for our esteemed journal, your pivotal role revolves around ensuring the quality, integrity, and timely dissemination of groundbreaking research within the realm of Biomedical, Bioscience, Bioengineering, and Biotechnology. This detailed guide is designed to equip you with the necessary instructions and best practices to navigate the editorial process with proficiency and efficacy. Your dedication and commitment as an editor are invaluable to the success and reputation of BioMed and BioSci Advances.
Editorial Workflow:
Manuscript Handling:
Ethical Considerations:
Collaboration and Communication:
Continuous Improvement:
Publication Ethics for BioMed and BioSci Advances
At BioMed and BioSci Advances, published by Ariston Publications, we uphold the highest ethical standards in scientific publishing to ensure the integrity, credibility, and trustworthiness of the research we disseminate. Our commitment to ethical practices extends across all stages of the publication process, from manuscript submission to post-publication dissemination. Our publication ethics policies are designed to guide authors, reviewers, editors, and all stakeholders involved in the publishing process. Adherence to these ethical principles is paramount to maintain transparency, fairness, and trust in scholarly communication.
Authorship Criteria:
Originality and Plagiarism:
Conflict of Interest:
Data Integrity:
Editorial Integrity:
Conflict of Interest:
Editors are responsible for managing conflicts of interest transparently and impartially, ensuring that they do not compromise the integrity of the editorial process.
Transparency:
Editors should ensure transparency in the publication process by clearly communicating the editorial policies, peer review process, and any conflicts of interest.
Corrections and Retractions:
Ethical Concerns:
Any concerns about ethical issues, such as research misconduct or violations of publication ethics, will be thoroughly investigated by the journal and appropriate actions will be taken.
All stakeholders are expected to comply with the journal’s policies, guidelines, and ethical standards, as well as relevant regulatory requirements and best practices in scholarly publishing.
BioMed and BioSci Advances is committed to achieving high visibility and widespread dissemination of the research it publishes. While the journal is currently not indexed, we are actively working towards being indexed in prominent databases and directories relevant to Biomedicine, Bioscience, Bioengineering, and Biotechnology. Our goal is to ensure that the valuable and impactful research published in BioMed and BioSci Advances reaches a broad audience of scholars, researchers, and practitioners in the field.
We are in the process of applying for indexing in key databases and directories, such as Scopus, Web of Science, MEDLINE/PubMed and others, to enhance the visibility and discoverability of articles published in the journal. As we progress in our efforts to expand the journal’s indexing coverage, we aim to increase its impact and ensure that the research published in BioMed and BioSci Advances contributes to the advancement of knowledge and practical solutions in Biomedicine, Bioscience, Bioengineering, and Biotechnology. Stay tuned for updates as we work towards achieving these goals and further elevating the journal’s reach within the global scientific community.
At present, there are no article processing charges (APCs) associated with publishing in BioMed and BioSci Advances. As an open-access journal, all articles are published free of cost to authors. The publisher covers the expenses incurred in the publication process, allowing authors to disseminate their research without any financial burden. There are no fees for submission, processing, or publication of articles in BioMed and BioSci Advances. This approach ensures equitable access to scientific knowledge and supports the dissemination of research findings across the global scientific community.
BioMed and BioSci Advances welcomes proposals for special issues that align with the journal’s aims, scope and objectives. Special issues provide an opportunity to delve into specific topics or emerging areas within Biomedicine, Bioscience, Bioengineering, Biotechnology and related fields, offering a focused platform for in-depth exploration and discussion.
If you have a proposal for a special issue, please submit it to the editorial office for consideration. Your proposal should include a brief outline of the proposed topic, its significance and relevance to the field, potential contributors, and a proposed timeline for publication.
Once your proposal is received, it will undergo careful evaluation by the editorial team to assess its suitability for publication in BioMed and BioSci Advances. If approved, you will be invited to serve as a guest editor or co-editor for the special issue, working closely with the editorial team to oversee the review and publication process.
We look forward to receiving your proposals and collaborating with you to bring forth exciting and impactful special issues for our readership.
Please submit the special issue proposal at: info@aristonpubs.com
BioMed and BioSci Advances welcomes the opportunity to collaborate with organizers of conferences, symposiums, and workshops to publish special issues or proceedings featuring research articles presented at these events.
If you are organizing a conference or similar academic gathering and wish to publish selected research papers in BioMed and BioSci Advances, we encourage you to reach out to our editorial office with your proposal. Your proposal should include details such as the theme and scope of the conference, the number of anticipated submissions, and a proposed timeline for publication.
Upon receiving your proposal, our editorial team will review it carefully to assess its alignment with the journal’s scope and objectives. If approved, we will work closely with you to facilitate the submission and review process for the conference papers, ensuring timely publication in a dedicated special issue or proceeding.
By publishing conference-related research in BioMed and BioSci Advances, authors can benefit from the journal’s wide readership and open access model, maximizing the visibility and impact of their work within the Biomedical, Bioscience, Bioengineering, and Biotechnology community. We look forward to the opportunity to collaborate with you on showcasing cutting-edge research from your conference in our journal.
Mat Both Dol, Delelegn Woyessa, Shiferaw Demissie, M. Sadre Alam Fakhri
Summary: This research isolated and characterized native Trichoderma strains from tomato rhizospheres in Ethiopia to evaluate their antagonistic effects against P. infestans. Ten isolates were obtained, and four strains exhibited substantial growth inhibition of the pathogen, with Ju-TGDb-2 showing the highest efficacy (61.4%). These findings suggest that native Trichoderma isolates can be used as effective biocontrol agents, offering a promising solution for managing late blight in tomatoes.
BioMed and BioSci Advances 2(2), 105-113 (2025)
https://doi.org/10.69626/bba.2025.0105.